Product Code: ETC12893772 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Macular Degeneration Treatment Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Macular Degeneration Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Macular Degeneration Treatment Market - Industry Life Cycle |
3.4 Netherlands Macular Degeneration Treatment Market - Porter's Five Forces |
3.5 Netherlands Macular Degeneration Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Netherlands Macular Degeneration Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Netherlands Macular Degeneration Treatment Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Netherlands Macular Degeneration Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Netherlands Macular Degeneration Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of macular degeneration in the aging population of the Netherlands |
4.2.2 Technological advancements in treatment options for macular degeneration |
4.2.3 Growing awareness about the importance of early detection and treatment of the disease |
4.3 Market Restraints |
4.3.1 High cost associated with macular degeneration treatment |
4.3.2 Limited access to specialized healthcare services in certain regions of the Netherlands |
5 Netherlands Macular Degeneration Treatment Market Trends |
6 Netherlands Macular Degeneration Treatment Market, By Types |
6.1 Netherlands Macular Degeneration Treatment Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Macular Degeneration Treatment Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Netherlands Macular Degeneration Treatment Market Revenues & Volume, By Dry Macular Degeneration, 2021 - 2031F |
6.1.4 Netherlands Macular Degeneration Treatment Market Revenues & Volume, By Wet Macular Degeneration, 2021 - 2031F |
6.2 Netherlands Macular Degeneration Treatment Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Macular Degeneration Treatment Market Revenues & Volume, By Anti-VEGF Therapy, 2021 - 2031F |
6.2.3 Netherlands Macular Degeneration Treatment Market Revenues & Volume, By Photodynamic Therapy, 2021 - 2031F |
6.2.4 Netherlands Macular Degeneration Treatment Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.3 Netherlands Macular Degeneration Treatment Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Macular Degeneration Treatment Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Netherlands Macular Degeneration Treatment Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.4 Netherlands Macular Degeneration Treatment Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4 Netherlands Macular Degeneration Treatment Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Macular Degeneration Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.3 Netherlands Macular Degeneration Treatment Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.4 Netherlands Macular Degeneration Treatment Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
7 Netherlands Macular Degeneration Treatment Market Import-Export Trade Statistics |
7.1 Netherlands Macular Degeneration Treatment Market Export to Major Countries |
7.2 Netherlands Macular Degeneration Treatment Market Imports from Major Countries |
8 Netherlands Macular Degeneration Treatment Market Key Performance Indicators |
8.1 Average age of diagnosis of macular degeneration |
8.2 Number of ophthalmologists specializing in macular degeneration treatment per capita |
8.3 Percentage of the population undergoing regular eye screenings for early detection of macular degeneration |
9 Netherlands Macular Degeneration Treatment Market - Opportunity Assessment |
9.1 Netherlands Macular Degeneration Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Netherlands Macular Degeneration Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Netherlands Macular Degeneration Treatment Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Netherlands Macular Degeneration Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Netherlands Macular Degeneration Treatment Market - Competitive Landscape |
10.1 Netherlands Macular Degeneration Treatment Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Macular Degeneration Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |